Skip to main content
Equibles

Jones Hill Capital LP

Position in CAPR — Capricor Therapeutics, Inc.

CIK 2102314 NEW YORK, NY
Back to CAPR Full portfolio

Position in CAPR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$10,131,684
-$17,508,208 QoQ
Shares Held
420,751
-53.7% QoQ
Ownership
0.724%
of shares outstanding
% of Portfolio
2.21%
of 13F equity value
Holder Rank
#22
of 170 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CAPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Jones Hill Capital LP holds $379,449,729 across 26 Biotechnology names. CAPR ranks #11 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BMRN
Biomarin Pharmaceutical Inc
 1,431,590 $81,915,579
2 ARQT
Arcutis Biotherapeutics, Inc.
 1,089,701 $28,571,960
3 MDGL
Madrigal Pharmaceuticals, Inc.
 52,545 $28,214,037
4 BCAX
Bicara Therapeutics Inc.
 892,621 $26,501,917
5 RLMD
Relmada Therapeutics, Inc.
 3,655,075 $25,293,119
6 TRVI
Trevi Therapeutics, Inc.
 1,339,212 $24,976,303
7 PHVS
Pharvaris N.V.
 677,879 $23,441,055
8 XENE
Xenon Pharmaceuticals Inc.
 367,900 $22,206,444

All Filings in CAPR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,131,684 420,751
2026-03-31 $27,639,892 909,207